GlassScriptPhysician profile
Corey S Cagwin
NPI 1093410284
$1,989.69
in general payments reported to CMS, 2019-2025
9 companies · $1,025 in 2025
The $1,025 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $965 · 2025: $1,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,793 · Education: $137 · Travel and Lodging: $59.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,793.08 |
| Education | $137.01 |
| Travel and Lodging | $59.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $993.22 | 2024-2025 | Mako, Insignia, Tritanium |
| Medical Device Business Services, INC. | $545.43 | 2024-2025 | Stratafix |
| Ethicon US, LLC | $255.61 | 2025 | Vistaseal, Stratafix |
| Vertex Pharmaceuticals Incorporated | $54.12 | 2025 | |
| Smith+Nephew, INC. | $40.23 | 2024-2025 | Multifix |
| Sanara Medtech INC. | $39.30 | 2024 | Celleraterx |
| Acera Surgical, INC. | $24.71 | 2025 | Restrata Wound Matrix |
| Coastal Medical Technologies LLC | $20.64 | 2024 | |
| Fidia Pharma USA INC. | $16.43 | 2025 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Cagwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.